A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks

NCT02720991 ↗

Phase 4 Completed 50 enrolled Gynuity Health Projects Hopital La Rabta · collab

NaSingle-groupOpen-labelTreatment

Summary

A pilot study on the acceptability and feasibility with Mifepristone and 400 mg of sub-lingual Misoprostol between 71-77 and 78-84 days of gestation for 50 cases.

Timeline

Start: 2014-07
Primary completion: 2015-04
Completion: 2015-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mifepristone	Small molecule	200 mg	Oral
Subject	Misoprostol	Other / unclassified	400 ug	Other

Indications

No indication recorded.